Item 8.01. Other Events.

On January 27, 2020, Merit Medical Systems, Inc. (the "Company") issued a press release announcing that the Company had received a notice on January 24, 2020 from Starboard Value LP ("Starboard") of Starboard's intention to nominate individuals to the Company's Board of Directors at the Company's 2020 Annual Meeting of Shareholders. A copy of the Company's press release is filed as Exhibit 99.1 hereto and is incorporated herein by reference.

Important Additional Information and Where to Find It

The Company plans to file a proxy statement (the "2020 Proxy Statement") with the SEC in connection with the solicitation of proxies for the Annual Meeting, together with a BLUE proxy card. SHAREHOLDERS ARE URGED TO READ THE 2020 PROXY STATEMENT (INCLUDING ANY AMENDMENTS OR SUPPLEMENTS THERETO) AND ANY OTHER RELEVANT DOCUMENTS THAT THE COMPANY FILES WITH THE SEC CAREFULLY IN THEIR ENTIRETY WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION.

Shareholders will be able to obtain, free of charge, copies of the 2020 Proxy Statement, any amendments or supplements thereto and any other documents (including the BLUE proxy card) when filed by the Company with the SEC in connection with the Annual Meeting at the SEC's website (http://www.sec.gov), at the Company's website (http://www.merit.com/investors) or by contacting Innisfree M&A Incorporated by phone at (888) 750-5834, by email at info@innisfreema.com or by mail at 501 Madison Avenue, 20th Floor, New York, NY 10022.

Item 9.01.Financial Statements and Exhibits.





(d)       Exhibit



EXHIBIT NUMBER                               DESCRIPTION

99.1                Press Release, dated January 27, 2020, entitled "Merit Medical
                  Issues Statement Regarding Director Nominations from Starboard."

104               Cover Page Interactive Data File - the cover page XBRL tags are
                  embedded within the Inline XBRL document







                                       2

© Edgar Online, source Glimpses